Nabila Ikhelef-Gribi

Title: Nabila Ikhelef-Gribi: Innovator in Vaccine Storage Technology

Introduction

Nabila Ikhelef-Gribi is a notable inventor based in Francheville, France. She has made significant contributions to the field of vaccine storage technology, holding 2 patents that focus on optimizing the stability of vaccine compositions.

Latest Patents

Her latest patents include a method of storing a vaccine containing an aluminum adjuvant. This invention relates to a method for loading and storing a vaccine composition, which contains the antigen adsorbed on the aluminum adjuvant. The method comprises loading the composition into a container and closing the container with a device that acts as a stopper. The surface of this device, which comes into contact with the composition, is coated with a fluoropolymer such as Teflon™ or polymerized silicone. The use of these materials optimizes the stability of the adsorbed antigen during storage. In a particular embodiment, the antigen is the hepatitis B surface antigen, and the aluminum adjuvant is aluminum oxy hydroxide.

Career Highlights

Nabila has worked with prominent companies in the pharmaceutical industry, including Sanofi Pasteur Inc. and Sanofi Pasteur SA. Her experience in these organizations has contributed to her expertise in vaccine development and storage solutions.

Collaborations

Throughout her career, Nabila has collaborated with talented professionals, including Julien Tirefort and Sandrine Lentsch Graf. These collaborations have further enhanced her innovative work in the field.

Conclusion

Nabila Ikhelef-Gribi is a pioneering inventor whose work in vaccine storage technology is making a significant impact. Her innovative methods are crucial for improving the stability and efficacy of vaccines, ultimately contributing to public health advancements.